144 related articles for article (PubMed ID: 15803357)
21. The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer.
Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Wolf G; Wascher TC; Paulweber B; Samonigg H
Cancer Lett; 2004 Mar; 206(1):59-62. PubMed ID: 15019160
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
Wagner K; Hemminki K; Israelsson E; Grzybowska E; Söderberg M; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Försti A
Breast Cancer Res Treat; 2005 Jul; 92(2):133-40. PubMed ID: 15986122
[TBL] [Abstract][Full Text] [Related]
23. A role for XRCC4 in age at diagnosis and breast cancer risk.
Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
25. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.
Wieczorek S; Hellmich B; Arning L; Moosig F; Lamprecht P; Gross WL; Epplen JT
Arthritis Rheum; 2008 Jun; 58(6):1839-48. PubMed ID: 18512809
[TBL] [Abstract][Full Text] [Related]
26. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma.
Wei YS; Lan Y; Tang RG; Xu QQ; Huang Y; Nong HB; Huang WT
Clin Immunol; 2007 Dec; 125(3):309-17. PubMed ID: 17720627
[TBL] [Abstract][Full Text] [Related]
27. The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.
Wu JM; Bensen-Kennedy D; Miura Y; Thoburn CJ; Armstrong D; Vogelsang GB; Hess AD
Biol Blood Marrow Transplant; 2005 Jun; 11(6):455-64. PubMed ID: 15931634
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-10 promoter polymorphisms and atopic asthma in North Indians.
Chatterjee R; Batra J; Kumar A; Mabalirajan U; Nahid S; Niphadkar PV; Ghosh B
Clin Exp Allergy; 2005 Jul; 35(7):914-9. PubMed ID: 16008678
[TBL] [Abstract][Full Text] [Related]
29. IL-1 gene polymorphisms and genetic susceptibility of gallbladder cancer in a north Indian population.
Vishnoi M; Pandey SN; Choudhuri G; Mittal B
Cancer Genet Cytogenet; 2008 Oct; 186(2):63-8. PubMed ID: 18940468
[TBL] [Abstract][Full Text] [Related]
30. Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.
Lei H; Hemminki K; Altieri A; Johansson R; Enquist K; Hallmans G; Lenner P; Försti A
Breast Cancer Res Treat; 2007 May; 103(1):61-9. PubMed ID: 17033924
[TBL] [Abstract][Full Text] [Related]
31. Predictive value of interleukin-10 promoter genotypes and haplotypes in determining the susceptibility to nephropathy in type 2 diabetes patients.
Mtiraoui N; Ezzidi I; Kacem M; Ben Hadj Mohamed M; Chaieb M; Haj Jilani AB; Mahjoub T; Almawi WY
Diabetes Metab Res Rev; 2009 Jan; 25(1):57-63. PubMed ID: 19031431
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma.
Bogunia-Kubik K; Mazur G; Wróbel T; Kuliczkowski K; Lange A
Tissue Antigens; 2008 Feb; 71(2):146-50. PubMed ID: 18201362
[TBL] [Abstract][Full Text] [Related]
33. A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma.
Romero JM; Sáenz-López P; Cózar JM; Carretero R; Canton J; Vazquez F; Concha A; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2009 Jan; 70(1):60-4. PubMed ID: 19027043
[TBL] [Abstract][Full Text] [Related]
34. The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk.
Yu KD; Chen AX; Yang C; Fan L; Huang AJ; Shao ZM
Breast Cancer Res Treat; 2012 Jan; 131(1):27-31. PubMed ID: 20737205
[TBL] [Abstract][Full Text] [Related]
35. Genetic variants of interleukin-1RN and interleukin-1beta genes and risk of cervical cancer.
Singh H; Sachan R; Goel H; Mittal B
BJOG; 2008 Apr; 115(5):633-8. PubMed ID: 18333945
[TBL] [Abstract][Full Text] [Related]
36. An association study of inflammatory cytokine gene polymorphisms in Fabry disease.
Safyan R; Whybra C; Beck M; Elstein D; Altarescu G
Eur Cytokine Netw; 2006 Dec; 17(4):271-5. PubMed ID: 17353161
[TBL] [Abstract][Full Text] [Related]
37. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
38. The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
Langsenlehner U; Yazdani-Biuki B; Eder T; Renner W; Wascher TC; Paulweber B; Weitzer W; Samonigg H; Krippl P
Clin Cancer Res; 2006 Feb; 12(4):1392-4. PubMed ID: 16489098
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-6 -174G/C polymorphism in breast cancer and uterine leiomyoma patients: a population-based case control study.
Litovkin KV; Domenyuk VP; Bubnov VV; Zaporozhan VN
Exp Oncol; 2007 Dec; 29(4):295-8. PubMed ID: 18199986
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
